These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37457750)

  • 1. Construction and Assessment of a Prognostic Risk Model for Cervical Cancer Based on Lactate Metabolism-Related lncRNAs.
    Gao Y; Liu H; Wan J; Chang F; Zhang L; Wang W; Zhang Q; Feng Q
    Int J Gen Med; 2023; 16():2943-2960. PubMed ID: 37457750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer.
    Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L
    Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of A Risk Signature Based on Lactic Acid Metabolism-Related LncRNAs in Patients With Esophageal Squamous Cell Carcinoma.
    Zhao F; Li Y; Dong Z; Zhang D; Guo P; Li Z; Li S
    Front Cell Dev Biol; 2022; 10():845293. PubMed ID: 35646892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a prognostic model of colon cancer patients based on metabolism-related lncRNAs.
    Li C; Liu Q; Song Y; Wang W; Zhang X
    Front Oncol; 2022; 12():944476. PubMed ID: 36248984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer.
    Li J; Zhang Y; Li C; Wu H; Feng C; Wang W; Liu X; Zhang Y; Cai Y; Jia Y; Qiao H; Wu F; Zhang S
    Front Genet; 2022; 13():956246. PubMed ID: 36276952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of four-metabolism related-long non-coding RNAs as potential signature in prognosis of colon cancer.
    Chen G; Dong Y; Shi W; Li L; Zhu W; Xie L; Song X
    Transl Cancer Res; 2022 Apr; 11(4):725-735. PubMed ID: 35571667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J; Liang Y; Gu JJ; Huang Y; Wang B
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [No Abstract]   [Full Text] [Related]  

  • 10. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
    Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
    BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
    Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
    BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Signature of Autophagy-Related Long Non-coding RNA to Predict the Prognosis of Breast Cancer.
    Li X; Chen J; Yu Q; Huang H; Liu Z; Wang C; He Y; Zhang X; Li W; Li C; Zhao J; Long W
    Front Genet; 2021; 12():569318. PubMed ID: 33796128
    [No Abstract]   [Full Text] [Related]  

  • 14. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
    Front Oncol; 2022; 12():833763. PubMed ID: 35280814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma.
    Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X
    Front Genet; 2022; 13():975905. PubMed ID: 36313456
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
    Pan Y; Zhang Q; Zhang H; Kong F
    Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis.
    Wang G; Mao Z; Zhou X; Zou Y; Zhao M
    J Gastrointest Oncol; 2022 Aug; 13(4):1640-1655. PubMed ID: 36092333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.